J.W. Coons Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.51M Buy
13,630
+3,137
+30% +$334K 0.34% 70
2025
Q1
$1.18M Buy
10,493
+48
+0.5% +$4.95K 0.31% 81
2024
Q4
$965K Buy
10,445
+75
+0.7% +$6.75K 0.25% 92
2024
Q3
$869K Buy
10,370
+35
+0.3% +$2.67K 0.22% 104
2024
Q2
$709K Sell
10,335
-324
-3% -$21.6K 0.17% 113
2024
Q1
$781K Sell
10,659
-471
-4% -$36.2K 0.18% 109
2023
Q4
$902K Buy
11,130
+300
+3% +$23.3K 0.24% 98
2023
Q3
$812K Buy
10,830
+50
+0.5% +$3.85K 0.23% 97
2023
Q2
$831K Hold
10,780
0.23% 100
2023
Q1
$894K Buy
10,780
+435
+4% +$36K 0.26% 90
2022
Q4
$888K Buy
10,345
+160
+2% +$12.7K 0.27% 90
2022
Q3
$628K Buy
10,185
+160
+2% +$10.1K 0.24% 113
2022
Q2
$620K Sell
10,025
-387
-4% -$24K 0.22% 120
2022
Q1
$621K Buy
10,412
+600
+6% +$38.4K 0.19% 136
2021
Q4
$714K Sell
9,812
-215
-2% -$14.8K 0.22% 116
2021
Q3
$702K Sell
10,027
-385
-4% -$27K 0.24% 105
2021
Q2
$718K Buy
10,412
+365
+4% +$24.4K 0.25% 102
2021
Q1
$648K Buy
10,047
+5
+0% +$322 0.23% 114
2020
Q4
$586K Sell
10,042
-420
-4% -$25.3K 0.22% 114
2020
Q3
$662K Buy
10,462
+1,580
+18% +$110K 0.28% 102
2020
Q2
$683K Buy
8,882
+1,676
+23% +$128K 0.3% 91
2020
Q1
$537K Buy
+7,206
New +$498K 0.28% 99

Other funds holding GILD

J.W. Coons Advisors's GILD Position: Q2 2025 in Review

J.W. Coons Advisors increased its Gilead Sciences (GILD) stake by 30% in Q2 2025, buying an estimated $334K and bringing the position to 13,630 shares worth $1.51M. The position accounts for 0.34% of the portfolio, ranked #70.

J.W. Coons Advisors first reported a position in GILD in Q1 2020 and has held it in 22 quarters since. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • J.W. Coons Advisors held 13,630 shares of Gilead Sciences worth $1.51M as of Q2 2025.
  • J.W. Coons Advisors bought 3,137 Gilead Sciences shares in Q2 2025, an estimated $334K.
  • Gilead Sciences made up 0.34% of J.W. Coons Advisors's portfolio in Q2 2025, its #70 holding.
  • J.W. Coons Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 22 quarters since.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on J.W. Coons Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.